Manas AI

The AI-Native Biopharmaceutical Company

New York, United States · Founded 2025 · $50.6M raised

Headquarters
New York, New York
Employees
1–10
Founded
2025
Business Model
B2B
Website
manasai.co
Total Funding
$50.6M
Last Round
$26.0M Extension RoundSep 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Manas AI is an end-to-end, AI-native biopharmaceutical company founded on the mission to cure human disease. The company builds and uses neuro-symbolic, science-based foundational models to discover transformative medicines and bring them to market. Co-founded by Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh, Manas AI is headquartered in New York.

Summary

Manas AI is a Life Sciences company based in New York, United States, founded in 2025. It has raised $50.6M in total across 2 rounds, most recently a $26.0M Extension Round in Sep 2025. Investors include The General Partnership, General Catalyst and Blitzscaling Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundSep 2025
$26.0M

Sign up to see all 2 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Manas AI on Indexed.vc
<a href="https://indexed.vc/companies/manas-ai"><img src="https://indexed.vc/api/badge/company/manas-ai" alt="Manas AI on Indexed.vc" width="260" height="76" /></a>